Literature DB >> 7514322

African swine fever virus structural protein p72 contains a conformational neutralizing epitope.

M V Borca1, P Irusta, C Carrillo, C L Afonso, T Burrage, D L Rock.   

Abstract

We have previously described a monoclonal antibody (mAb 135D4) to an unidentified 70- to 72-kDa African swine fever virus (ASFV) protein that exhibited high levels of neutralizing activity against various virulent ASFV isolates. Here, we identify the reactive ASFV protein as the major virus structural protein p72. In vitro-translated products of the p72 protein gene were specifically immunoprecipitated by mAb 135D4. Immunoprecipitation of a nested set of truncated p72 in vitro translation products defined the region between amino acid residues 400 and 404 as necessary for mAb 135D4 reactivity. Five partially overlapping peptides (15mers) covering residues 388-446 failed to react with mAb 135D4, suggesting the conformational dependence of the epitope. Supporting this interpretation, larger in vitro translation products representing residues 56-282, 159-361, 360-508, and 507-646 also failed to react with mAb 135D4. Consistent with its involvement in virus neutralization, immunoelectromicroscopy, using a rabbit antiserum against mAb 135D4-purified p72, located the protein on the surface of unenveloped virus particles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514322     DOI: 10.1006/viro.1994.1311

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  African swine fever virus structural protein pE120R is essential for virus transport from assembly sites to plasma membrane but not for infectivity.

Authors:  G Andrés; R García-Escudero; E Viñuela; M L Salas; J M Rodríguez
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Phenotype-based identification of host genes required for replication of African swine fever virus.

Authors:  Annie C Y Chang; Laszlo Zsak; Yanan Feng; Ronen Mosseri; Quan Lu; Paul Kowalski; Aniko Zsak; Thomas G Burrage; John G Neilan; Gerald F Kutish; Zhiqiang Lu; Will Laegreid; Daniel L Rock; Stanley N Cohen
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  The major structural protein of African swine fever virus, p73, is packaged into large structures, indicative of viral capsid or matrix precursors, on the endoplasmic reticulum.

Authors:  C Cobbold; T Wileman
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice.

Authors:  Xinxin Chen; Jifei Yang; Yanhong Ji; Edward Okoth; Bin Liu; Xiaoyang Li; Hong Yin; Qiyun Zhu
Journal:  Virol Sin       Date:  2016-03-11       Impact factor: 4.327

5.  African swine fever virus is wrapped by the endoplasmic reticulum.

Authors:  I Rouiller; S M Brookes; A D Hyatt; M Windsor; T Wileman
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Involvement of the endoplasmic reticulum in the assembly and envelopment of African swine fever virus.

Authors:  C Cobbold; J T Whittle; T Wileman
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  African swine fever virus replication in the midgut epithelium is required for infection of Ornithodoros ticks.

Authors:  S B Kleiboeker; G A Scoles; T G Burrage; J Sur
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  A structural DNA binding protein of African swine fever virus with similarity to bacterial histone-like proteins.

Authors:  M V Borca; P M Irusta; G F Kutish; C Carillo; C L Afonso; A T Burrage; J G Neilan; D L Rock
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Thoughts on African Swine Fever Vaccines.

Authors:  Daniel L Rock
Journal:  Viruses       Date:  2021-05-20       Impact factor: 5.048

10.  DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies.

Authors:  Jordi M Argilaguet; Eva Pérez-Martín; Miquel Nofrarías; Carmina Gallardo; Francesc Accensi; Anna Lacasta; Mercedes Mora; Maria Ballester; Ivan Galindo-Cardiel; Sergio López-Soria; José M Escribano; Pedro A Reche; Fernando Rodríguez
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.